Our results show that end-tidal capnography is an unreliable tool for monitoring and targeting invasive ventilation at least in the initial treatment of patients with severe TBI. Although the majority of the patients in this study were ventilated within the target range of EtCO2 values, many were unwittingly hypercapnic in the first blood gas sample after arriving in the hospital. Our data show a large variability in the calculated CO2 gap in this patient cohort and it was more pronounced in patients with lower EtCO2. This underestimation of PaCO2 when EtCO2 was used to guide ventilation caused hypoventilation despite normal EtCO2 values. An increased CO2 gap and the resulting hypercapnia were associated with increased in-hospital mortality. This underlines the clinical importance of these findings and the need for either a more reliable surrogate parameter for PaCO2 estimation or early PaCO2 sampling in the prehospital management of patients with TBI.
The CO2 gap
Previous studies have observed that the CO2 gap is multifactorial, with possible causes including ventilation-perfusion mismatch, increased dead space, or, shock with impaired perfusion and temperature [11,24]. However, most of these factors influencing the CO2 gap are not measurable, detectable or predictable in the initial treatment period in the field or ER. The ability to predict or gauge the CO2 gap based on the patient’s condition is consequently limited. In this context the CO2 gap might be both, an indicator of severity of injury, and a predictor of impaired survival in patients with severe traumatic brain injury.
Two recent publications investigated the CO2 gap in critically ill patients after prehospital emergency anesthesia [25,26]. Their findings are in line with our results and showed only moderate correlation between EtCO2 and PaCO2, confirming that EtCO2 alone should be used with caution to guide ventilation in the critically ill.
In a cohort of cardiac arrest patients, Suominen et al. showed an association between an increased CO2 gap and in-hospital mortality 24 hours after return of spontaneous circulation (ROSC). Our data is in line with these findings and reinforces the plausibility of this association by controlling for potential confounding due to shock or hypoperfusion in a multivariate logistic regression model.
EtCO2 as a surrogate marker
PaCO2 is considered to be the major determinant of cerebral blood flow (CBF) through its effects on cerebral vascular tone [27]. This reinforces the importance of precise ventilatory control in the initial management of TBI. It is known that even modest hypercapnia can result in substantial increases in ICP and can cause dangerous cerebral ischemia when intracranial compliance is poor [28]. Therefore, we hypothesize that the hypoventilation due to underestimation of the arterial CO2 using EtCO2 as a surrogate marker leads to impaired CBF and thereby increases mortality.
Recent TBI guidelines rely on the assumption that the CO2 gap is approximately 0.5 kPa (3.8 mmHg). However, these assumptions are based on data of individuals undergoing general anesthesia without major comorbidities or trauma [11,29]. In this study, the mean first EtCO2 was 4.6 ±0.78 kPa, whereas the mean PaCO2 was 6.26 ±1.03 kPa and far in excess of the target of 4.5 to 5.0 kPa. Therefore, relying on EtCO2 as a surrogate for PaCO2 provides a false sense of security, and providers may not achieve optimal prehospital PaCO2. At present, no reliable alternative to direct ABG sampling seems to exist in order to approximate PaCO2 reliably.
However, to our best knowledge, there is no data supporting the routine use of point-of-care blood gas analyses in patients mechanically ventilated in the field. This lack of data could be due to the fact that up to now the importance of point-of-care testing in prehospital care has been underestimated, due to the high reliance on proxy markers like EtCO2. Further studies on the optimal timing of sampling after intubation and the beginning of mechanical ventilation, as well as the optimal sampling interval, are needed. We postulate that a single ABG sample post-intubation could gauge the individual CO2 gap and ensure more reliable EtCO2-guided ventilation.
Factors influencing mortality
Our data showed a significant age difference between survivors and non-survivors. Age was independently and significantly associated with mortality. Besides the fact that age might be a surrogate for unrecognized confounders due to comorbidities that negatively influence mortality, clinical decision-making may also play a role. In daily routine, palliation might be considered at an earlier stage in elderly trauma victims with limited rehabilitation potential, whereas younger trauma patients may receive maximum therapeutic interventions [30].
In our cohort, systolic blood pressure and ISS thorax scores were not significantly associated with mortality in the multivariate analysis.
Limitations
This study had several limitations. First, it is a retrospective and single-center cohort study with a limited sample size. However, data was almost complete and multivariate adjustments were performed. Second, in order to increase the number of eligible patients in this study, we included patients who had an ABG sample up to 30 min after hospital arrival. However, a sensitivity analysis showed that the observed gradient between EtCO2 and PaCO2 was not significantly associated with the time between arterial blood gas sampling and the documented EtCO2. Still, it is possible that a proportion of the gradient between EtCO2 and PaCO2 was due to changes in ventilation settings during this period.